Appeal No. 1999-2200 Application No. 08/896,063 THE KAINATE CLASS OF GLUTAMATE RECEPTORS I. The EAA3C & EAA3D Subclass: Appeal No. 1999-035028 Application No. 08/189,738 Claim 23 is illustrative of the subject matter on appeal and is reproduced below: 23. A method of assaying a test ligand for binding to a human CNS receptor, which comprises the steps of incubating the test ligand under appropriate conditions with a human EAA-3 receptor-producing cell or with a membrane preparation derived therefrom which contains said EAA3 receptor and then determining the extent of binding between the human EAA3 receptor and the test ligand, wherein said cell has been engineered genetically to produce a kainate-binding human EAA receptor having incorporated expressibly therein a heterologous DNA molecule that codes for a human EAA3 receptor selected from the group consisting of: a human EAA3a receptor having the amino acid sequence of SEQ ID NO:2, a human EAA3b receptor having the amino acid sequence of SEQ ID NO:2 with the exception that the amino acid at position 639 is asparagine instead of aspartate, a human EAA3c receptor having the amino acid sequence of SEQ ID NO:17, and a human EAA3d receptor having the amino acid sequence of SEQ ID NO:18. 28 We recognize appellants’ request (Paper No. 25, received May 5, 1997) for oral hearing in this appeal. However, in our review of this appeal we find a hearing is not necessary. 37 CFR § 1.194(c). Accordingly, we make our decision on brief. 11Page: Previous 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 NextLast modified: November 3, 2007